Results 191 to 200 of about 308,418 (340)

Crocetin Impairs the Cytochrome P450 Epoxygenase Pathway toward Potentiating the Therapeutic Efficacy of Paclitaxel in Metastatic Breast Cancer. [PDF]

ACS Omega
Manhas D, Kaur G, Bhardwaj M, Kour H, Akhter MQ, Jamwal A, Sharma S, Singh PP, Bag S, Goswami A, Nandi U.   +10 more
europepmc   +1 more source

Engineered RNA Devices for In Vivo Targeted Therapeutics via Advanced Delivery Systems

Aggregate, EarlyView.
Schematic illustration of engineered RNA devices for in vivo targeted therapeutics via advanced delivery systems. ABSTRACT Engineered RNA devices can identify disease‐specific markers and precisely regulate gene expression, which is of great significance to the development of precision medicine.
Wei Luo, Xia Liu, Ying Han, Yijing Duan, Chuao Yu, Na Kong, Tian Xie   +6 more
wiley   +1 more source

Tailored Core‐Shell Nanocarrier for Therapeutic Drug Delivery via Visible Light Activation

Angewandte Chemie, EarlyView.
A core‐shell nanocarrier activated by visible light, composed of poly(3‐octylthiophene‐2,5‐diyl) (POT), iron oxide (II, III) (Fe3O4), polyvinyl alcohol (PVA), and trazodone tetraphenylborate (TRZ+ TPB−). During POT photooxidation (POT+), TRZ+ is liberated driven by the maintenance of particle's electroneutrality.
Deric Andrade‐Alarcón, Víctor de la Asunción‐Nadal, Gastón A. Crespo, María Cuartero   +3 more
wiley   +2 more sources

Design of electrochemical aptameric biosensor for the specific and selective detection of chemotherapeutic drugs: Application for paclitaxel and leucovorin. [PDF]

Sci Rep
Alanazi S, Rhouati A, Chrouda A, Cialla-May D, Popp J, Zourob M.   +5 more
europepmc   +1 more source

Paclitaxel and gemcitabine in advanced non-nasopharyngeal head and neck cancer: A phase II study conducted by the Hellenic Cooperative Oncology Group

, 1999
George Fountzilas, George P. Stathopoulos, C. Nicolaides, Anna Kalogera‐Fountzila, Haralabos P. Kalofonos, Angelos Nikolaou, C. Bacoyiannis, Epaminontas Samantas, C. Papadimitriou, P. Kosmidis, J. Daniilidis, N. Pavlidis   +11 more
openalex   +1 more source

Recall Reaction of a Severe Local Peripheral Neuropathy After Paclitaxel Extravasation [PDF]

, 1996
Manuel Hidalgo, Jordi Moreno Benito, Rámón Colomer, Luis Paz‐Ares   +3 more
openalex   +1 more source

AI‐Driven Microphysiological Systems for Advancing Nanoparticle Therapeutics

Advanced Intelligent Systems, EarlyView.
This review outlines recent advances in integrating artificial intelligence with microphysiological systems for nanoparticle evaluation. It highlights data‐driven optimization, image‐based prediction, and AI‐enabled analysis frameworks that advance translational research and support the development of personalized nanomedicine. Nanoparticles (NPs) play
Yedam Lee, Jaehong Min, Sujin Kim, Jihoon Ko   +3 more
wiley   +1 more source

First-line treatment with chemotherapy, surufatinib (an angio-immuno kinase inhibitor), and camrelizumab (an anti-PD-1 antibody) for locally advanced or metastatic pancreatic ductal adenocarcinoma: a phase Ib/II randomized study. [PDF]

Signal Transduct Target Ther
Jia R, Si HY, Fan MJ, Zhang N, Deng GC, Liu FF, Han L, Gou MM, Tan ZL, Zhang X, Wang YR, Shi Y, Zhang YY, Jia YS, Wang YQ, Han QL, Wang ZK, Dai GH.   +17 more
europepmc   +1 more source

Paclitaxel in Doxorubicin-Resistant Metastatic Breast Cancer Patients [PDF]

, 1995
Anjali Anand, Anjali Anand
openalex   +1 more source

CD30 as a Target Molecule in the Diagnosis and Therapy of Lymphomas

American Journal of Hematology, EarlyView.
ABSTRACT The tumor necrosis factor (TNF)‐receptor superfamily 8 receptor CD30 molecule is expressed in all tumor cells of Hodgkin lymphoma and anaplastic large cell lymphoma but is only weakly expressed in a small subset of large lymphoid cells in normal peripheral lymphoid tissues.
Harald Stein, Brunangelo Falini
wiley   +1 more source